Navigation Links
Endocare Receives NASDAQ Deficiency Letter Regarding Stockholders' Equity
Date:5/27/2009

t; the risk that intense competition and rapid technological and industry change may make it more difficult for Endocare to achieve significant market penetration; and uncertainty regarding the ability to secure and protect intellectual property rights relating to Endocare's technology. The actual results that Endocare achieves may differ materially from any forward-looking statements due to such risks and uncertainties. There can be no assurance that the proposed merger and financing will in fact be consummated, or that Endocare's board of directors will determine that HealthTronics' proposal constitutes a "Superior Proposal" under its merger agreement with Galil or, if it makes such a determination, that a transaction with HealthTronics will be consummated. Except as otherwise required by law, the Company undertakes no obligation to revise, or update publicly, any forward-looking statements for any reason.

    Investor Contact:     Media Contact:        For Additional Information:
    Matt Clawson          Len Hall              Michael R. Rodriguez, CFO
    Allen & Caron, Inc.   Allen & Caron, Inc.   Endocare, Inc.
    (949) 474-4300        (949) 474-4300        (949) 450-5400
    matt@allencaron.com   len@allencaron.com    www.endocare.com
    www.allencaron.com    www.allencaron.com


'/>"/>
SOURCE Endocare, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Endocare Stock to Commence Trading on NASDAQ
2. Endocare Reports 2007 Third Quarter and Nine-Month Results
3. Endocare Announces That National Cancer Institute to Sponsor Study Comparing Cryoablation to Radiation Therapy for Pain Relief in Bone Cancer Patients
4. Endocare Reports 2007 Annual and Fourth Quarter Financial Results
5. Endocare to Present at the B. Riley & Co. 9th Annual Las Vegas Investor Conference
6. Endocare Reports Financial Results for Second Quarter 2008
7. Endocare Comments on Unsolicited Proposal
8. Endocare and Former CFO Agree to Terminate Indemnification Agreement
9. Endocare to Present at Oppenheimer 19th Annual Healthcare Conference
10. Endocare and Galil Medical Sign Definitive Merger Agreement
11. Endocare to Present at 2nd Annual OneMedForum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Rolling Meadows, Ill. (PRWEB) , ... September 01, ... ... medical procedures done by members of the American Society for Dermatologic Surgery, according ... case. , The 2015 ASDS Consumer Survey on Cosmetic Dermatologic Procedures – which ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... is now offering the MonaLisa Touch® , an innovative vaginal health laser ... Touch® is a new hormone-free treatment for atrophic vaginitis, a condition that causes ...
(Date:9/1/2015)... ... September 01, 2015 , ... With former IBMers among its founding members, ... its inception more than 35 years ago. A pilot program begun by the company ... and, not just those intent on pursuing careers in these fields. The program is ...
(Date:9/1/2015)... ... 2015 , ... WorkCare, Inc., a national occupational health services ... as an Associate Medical Director. , WorkCare specializes in workforce health protection ... abroad. , Dr. Nelson has a diverse background. He trained in sports ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... Laboratory Instruments in accordance with GMP requirements“ , featuring Ed Szczesny (Quality Assurance, ... 2015 at 11:00 EDT (15:00 GMT). , Calibration, qualification, and the appropriate ...
Breaking Medicine News(10 mins):Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 3Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2
... evaluationGRAND RAPIDS, Mich., Feb. 13 Sentinel Group announced ... Sense(TM) Device. The study was conducted at Galenia ... MD, James Foote MD and Mexican doctor Jorge Trevino ... the devices implanted for 6 weeks to evaluate weight ...
... China,s leading,integrated medical device and healthcare services provider, ... HKEx: 8180) is pleased to,announce today the third ... ended December 31, 2008. The Group recorded HK$377,707,000 ... on a year-on-year basis. , ...
... (TSX:HAE) announces that it has implemented cost-cutting measures in ... Company will continue to seek financing and will initiate ... merger of the Company. , Haemacure has been seeking ... have expressed interest in an equity financing; however, this ...
... Stemedica Cell Technologies, Inc., a leader in adult stem cell development, ... Director of Manufacturing and Clinical Business Development of Stemedica International, CH. ... operations to Stemedica,s International,s center based in Lausanne, Switzerland. , ... ...
... in Superior Court for the Commonwealth of MassachusettsVANCOUVER, ... QLTI ; TSX: QLT) announced that on ... business as Massachusetts General Hospital ("MGH"), filed a ... of Massachusetts against QLT Phototherapeutics (Canada), Inc. QLT ...
... Results are better with brief immobilization than with bandage or ... People with severe ankle sprains recover faster with a short ... brace than with the use of either a tubular compression ... , Along with receiving one of the four ...
Cached Medicine News:Health News:Weight Loss Without Hunger! 2Health News:Golden Meditech Releases FY2008/09 Q3 Results 2Health News:Golden Meditech Releases FY2008/09 Q3 Results 3Health News:Haemacure Restructures - Seeks Financing or Sale of the Company 2Health News:Haemacure Restructures - Seeks Financing or Sale of the Company 3Health News:Stemedica Announces the Appointment of Riccardo Nisato, MBA, PhD as Director of Manufacturing and Clinical Business Development for Stemedica International 2Health News:Stemedica Announces the Appointment of Riccardo Nisato, MBA, PhD as Director of Manufacturing and Clinical Business Development for Stemedica International 3Health News:QLT announces that it is named as a defendant in an action 2Health News:QLT announces that it is named as a defendant in an action 3Health News:Casting Seems Best for Severe Ankle Sprains 2
(Date:9/1/2015)... , Sept. 1, 2015 Taiwan,s ... a press conference in Taipei ... its new Vaucarrin™ platform, a targeted drug delivery technology ... This event was part of a joint press ... Gold NanoTech Inc. (GNT), showcasing GNT,s latest edible gold-based ...
(Date:9/1/2015)... FELTON, California , September 1, 2015 /PRNewswire/ ... is segmented on the basis of sectors, ... of chronic diseases globally coupled with the increasing ... these diseases are expected to propel the growth ... to manage biological information efficiently is known as ...
(Date:9/1/2015)... , Aug. 31, 2015 Research and ... of the "Introduction to Veterinary Pharmacovigilance (London, ... offering. This course has been ... introduction to those concerned with Veterinary Pharmacovigilance. New ... who reqire a better understanding of veterinay drug ...
Breaking Medicine Technology:GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 3GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 4GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 5Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 4Introduction to Veterinary Pharmacovigilance Seminar (London, UK - September 23-24) 2
... Patients with Recurrent Ovarian Cancer ... the OVATURE Clinical Research Study, NEW CANAAN, Conn., Aug. ... of patients to OVATURE (OVArian,TUmor REsponse), a Phase III clinical ... http://www.OVATUREtrial.com is to inform,ovarian cancer patients about the ...
... Women Who Take DHA Have Healthier Pregnancies, Fewer Premature ... 50 nutritional,experts from a European Union (EU) committee now ... daily basis with a large amount,of DHA, an essential ... a growing array of health benefits, nutritional,supplementation of DHA ...
Cached Medicine Technology:A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol 2A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol 3A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol 4A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol 5A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol 6European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day 2
The MC-3 allows for simultaneous use of two lamps, with an additional built-in spare....
... a high light intensity. Light ... different brightness steps (Halogen 150) ... output can be adapted to ... small diameter scope, etc.). Different ...
Cold light source single outlet....
Cold light source single outlet....
Medicine Products: